|
Market Closed -
Nasdaq
16:00:00 2026-09-14 EDT
|
5-day change | 1st Jan Change | ||
| 5.320 USD | +0.19% |
|
-8.75% | +49.02% |
| 08-13 | Morgan Stanley Adjusts PT on Atea Pharmaceuticals to $7 From $6, Maintains Equalweight Rating | MT |
| 08-12 | Atea Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
| Market Cap | 427M 370M 349M 317M 594M 40.9B 598M 4.17B 1.61B 20.75B 1.6B 1.57B 65.96B | P/E 2026 * |
-3.02x | P/E 2027 * | -3.02x |
|---|---|---|---|---|---|
| Enterprise Value | 135M 117M 111M 100M 188M 12.96B 190M 1.32B 509M 6.57B 508M 497M 20.9B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 8.34x |
| Free-Float |
86.63% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AVIR | Delayed | |
CBOE
| AVIR | Real-time |
Last Transcript: Atea Pharmaceuticals, Inc.
| 1 day | +0.19% | ||
| 1 week | -8.75% | ||
| Current month | -0.56% | ||
| 1 month | +3.91% | ||
| 3 months | +18.49% | ||
| 6 months | -12.79% | ||
| Current year | +49.02% |
| 1 week | 5.17 |  | 5.66 |
| 1 month | 5.05 | | 5.9 |
| Current year | 3.28 | | 6.45 |
| 1 year | 2.78 | | 6.45 |
| 3 years | 2.46 | | 6.45 |
| 5 years | 2.46 | | 46.91 |
| 10 years | 2.46 | | 94.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 70 | 2012-11-30 | |
Andrea Corcoran
DFI | Director of Finance/CFO | 63 | 2020-09-30 |
Adam DeZure
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 2012-11-30 | |
Polly Murphy
BRD | Director/Board Member | 61 | 2020-07-31 |
Franklin Berger
BRD | Director/Board Member | 76 | 2019-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/18/26 | Buy | Director | 6,100 | 0.0077% | ||
| 3/11/26 | Exercice | Chief Financial Officer | 120,000 | 0.1536% | ||
| 1/31/26 | Exercice | Executive/Senior Manager | 215,256 | 0.2755% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.19% | -8.75% | +69.43% | +62.20% | 426M | |
| +5.04% | +3.66% | +50.62% | +103.77% | 66.93B | |
| +1.64% | -0.18% | +34.67% | +76.81% | 61.97B | |
| -3.18% | -0.78% | -14.14% | +369.82% | 28.26B | |
| +4.55% | +1.36% | +34.70% | +17.28% | 24.59B | |
| +2.20% | -4.72% | +2.19% | -13.14% | 24.3B | |
| +1.15% | -1.17% | +17.56% | -21.92% | 19.41B | |
| -7.03% | -10.19% | +161.91% | +303.00% | 16.77B | |
| +3.44% | -1.88% | -5.00% | +547.21% | 14.18B | |
| +4.96% | +4.63% | -2.75% | +864.40% | 14B | |
| Average | +1.30% | -3.83% | +34.92% | +230.94% | 27.08B | |
| Weighted average by Cap. | +1.98% | -1.96% | +33.31% | +172.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 30M 26M 24.53M 22.26M 41.75M 2.88B 42.05M 293M 113M 1.46B 113M 110M 4.64B |
| Net income | -146M -127M -119M -108M -203M -13.99B -205M -1.43B -549M -7.1B -548M -536M -22.57B | -147M -127M -120M -109M -205M -14.09B -206M -1.44B -553M -7.15B -552M -540M -22.72B |
| Net Debt | -291M -253M -238M -216M -406M -27.94B -409M -2.85B -1.1B -14.17B -1.09B -1.07B -45.05B | -176M -153M -144M -131M -246M -16.91B -247M -1.72B -664M -8.58B -663M -648M -27.28B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-14 | US$5.320 | +0.19% | 272,760 |
| 26-09-11 | US$5.310 | +2.51% | 489,582 |
| 26-09-10 | US$5.180 | -1.71% | 251,134 |
| 26-09-09 | US$5.270 | -7.22% | 430,819 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AVIR Stock
Select your edition
All financial news and data tailored to specific country editions
